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Background:Major depression (MDD) is characterized by altered emotion processing and deficits in cognitive control. In cognitive
interference tasks, patients with MDD have shown excessive amygdala activity and under-recruitment of dorsolateral prefrontal
cortex (DLPFC). The purpose of this study was to examine the effects of antidepressant treatment on anomalous neural activity in
cognitive-control and emotion-processing circuitry.
Methods: Functional magnetic resonance imaging was conducted on depressed patients (n=23) (both before and after
antidepressant treatment) compared with matched controls (n=18) while they performed a cognitive task involving attended and
unattended fear-related stimuli.
Results: After eight weeks of SSRI antidepressant treatment, patients with depression showed significantly increased DLPFC
activity to unattended fear-related stimuli and no longer differed from controls in either DLPFC or amygdala activity.
Conclusions: These results suggest that antidepressant treatment increases DLPFC under-activity during cognitive tasks that
include emotional interference.
Limitations: The sample was fairly homogeneous and this may limit generalizability.
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Major depression (MDD) involves abnormal emotion
processing and altered cognitive function, including
executive dysfunction. In particular, MDD patients show
deficits in managing cognitive interference when dis-
tracters have negative emotional valence (Mogg et al.,
1995). Tasks requiring control over interference usuallye.
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et al., 1999), and cognitive control of emotional responses
has also been shown to activate lateral prefrontal cortex
(PFC) (Ochsner and Gross, 2005). Recently we demon-
strated that when performing cognitive tasks that required
ignoring negatively-valenced distracters, MDD patients
showed under-activity in right DLPFC, and increased
activation in the amygdala (Fales et al., 2008). We
interpreted this finding as demonstrating simultaneous
amygdala over-activation and reduced cognitive control
over emotional responsiveness in MDD consistent with
reports showing decreased task-related connectivity
between DLPFC and amygdala (Siegle et al., 2007).
In the current study, we investigated the effects of
antidepressant treatment on functional brain activation
in MDD patients while performing the emotional in-
terference task described above. Antidepressants have
been found to normalize anomalies in resting activity in
the amygdala and to reduce amygdala responsiveness to
negative stimuli when presented outside of conscious
awareness (Sheline et al., 2001; Drevets, 2001). How-
ever, when stimuli are presented overtly, but unattended,
cognitive control is needed to resolve or prevent in-
terference. It is not yet clear whether antidepressant
therapy normalizes functional activity of prefrontal cor-
tex during cognitive control of amygdala responses. To
examine this question, we conducted a functional mag-
netic resonance imaging study of MDD patients both
before and after antidepressant treatment while they
performed a cognitive task involving attended and un-
attended fear-related stimuli. We predicted that, relative
to their premedicated state, MDD patients after medica-
tion would show increased lateral prefrontal response to
emotional distracters and reduced amygdala response.
2. Method
2.1. Participants
Depressed patients (n=23, males/females: 10/13,
with mean age: 36.4 years (SD 9.4)) all sought treatment
for depression, fulfilled DSM-IV criteria for major de-
pression as diagnosed by structured clinical interview
(SCID), and were matched with 18 demographically
similar healthy controls (M/F: 9/9, mean age: 33.4 years
(SD 8.2). Exclusionary criteria for all participants were
use of any psychotropic drugs within the last four weeks,
or the presence of any comorbid psychiatric illness or
complicating medical illness (Fales et al., 2008). Sixteen
patients had a current duration of depression less than
one year and seven patients had a depression duration
greater than one year. Mean age of depression onset was29.3 years. Before antidepressant treatment, the patients
had mean scores on the 17-item Hamilton Rating
Scale for Depression (HRSD) (Hamilton, 1960) of 20
(SD 2.3) while control participants had a mean score of
0.3 (SD .6). Depressed subjects' treatment histories con-
sisted of 17 with recurrent depression and 6 with first
episode, never treated. Of the 17 recurrent subjects,
eleven had a prior history of antidepressant treatment.
Eight had previously responded to treatment; one was a
partial responder; two were non-responders. Five pa-
tients had never been treated and one subject had an
inadequate duration of treatment to determine response.
Depressed subjects were started on escitalopram 10 mg/
day, initiated immediately following the first fMRI scan
and subsequent dose adjustment was determined by
clinical response. Ending doses of escitalopram were
20 mg (n=9) and 10 mg (n=8). Five participants were
treated with other antidepressants due to patient pref-
erence: sertraline 150 mg (n=3) sertraline 100 mg (n=1)
and paroxetine 20 mg. (n=2). Following eight weeks of
antidepressant treatment, the participants received a
second fMRI scan. At that time the patients' mean HRSD
score was 3.5 (SD 3.3), representing a mean reduction in
symptoms of 82%. After complete description of the
study to the participants, written informed consent was
obtained in accordance with criteria established by the
Washington University Human Subjects Committee.
2.2. Procedure
The emotion-interference task (Vuilleumier et al.,
2001; Bishop et al., 2004) presented participants with
a pair of houses and a pair of faces in each trial, with
one pair arranged horizontally and the other vertically
around a central fixation cross. Participants were in-
structed to attend to the horizontal or vertical axis for
a given block, and for each trial, the task was to tell
whether the two items in the target axis were the
same or different. There were four trial types: attend-
fearful-faces, attend-neutral-faces, ignore-fearful-faces
(attend to houses), and ignore-neutral-faces (attend to
houses).
2.3. fMRI imaging and analysis
2.3.1. Image acquisition and analysis
fMRI images were collected on a Siemens 3TAllegra
MRI scanner. The functional data were preprocessed and
analyzed using in-house software. A General Linear
Model (GLM) was defined for each participant, with
separate regressors to estimate hemodynamic response to
each combination of trial type (attention×emotion) and
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response types (see (Fales et al., 2008) for further details).
2.3.2. ROI identification
Our previous study (Fales et al., 2008) focused
specifically on regions linked to emotion processing
(rostral, pregenual and subgenual cingulate and amyg-
dala) or cognitive control (dorsal anterior cingulate and
dorsolateral prefrontal cortex) (Drevets and Raichle,
1998; Drevets et al., 1992; Botvinick et al., 2004;
Ochsner and Gross, 2005). We devised hand-drawn a
priori ROIs using published neuroanatomical guides
(Talairach and Tournoux, 1988; Rajkowska and Gold-
man-Rakic, 1995) to constrain our search for task-
related activity. Within this a priori focus, we then
identified regions that showed anomalous functional
activation patterns in unmedicated patients during theirFig. 1. Fear-minus-neutral activity in the right dorsolateral prefrontal corte
interaction of attention×emotion×group at time-1. The graphs show percent
indicates pre-treatment activations. Time 2 indicates post-antidepressant treatm
neutral faces (see Methods). IF indicates ignore-fearful-faces minus ignore-nfirst scanning session (time-1). For the current paper we
report on activity in these same regions at the time of the
second scan (time-2), after eight weeks of antidepressant
treatment for the patients.
3. Results
Of the initial 51 participants (24 controls and 27
depressed at time-1) (Fales et al., 2008), 41 returned at
time-2 (18 controls and 23 depressed). All time-1 effects
were significant both for the original sample (n=51) and
for the reduced sample (n=41). There were no sig-
nificant differences in depression or anxiety scores
between the 18 controls who returned at time-2 and the
six controls who did not, nor between the 23 patients
who returned and the four patients who did not
(independent t-tests, all psN .1).x and left amygdala. These regions showed a significant three-way
change in signal magnitude. Error bars indicate standard errors. Time 1
ent activations. AF is shorthand for attend-fearful-faces minus attend-
eutral faces.
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After eight weeks of antidepressant therapy, 14 out of
the 23 depressed subjects achieved 89% reduction or
better in depressive symptoms, as measured on the HDRS
scale. Seven showed 50–88% improvement, and the
remaining two showed 43–49% reductions. Thus in our
sample, approximately half the sample showed a very
significant improvement in symptoms, and all patients
responded at least partially to treatment.
3.2. Behavioral results
At time-1, depressed patients were significantly slower
than controls, but no less accurate. At time-2, the patients
showed a modest but non-significant improvement in
response time. (See Supplementary information for
details of behavioral data.)
3.3. Neuroimaging results
3.3.1. DLPFC
At time-1, a right DLPFC region showed a 3-way
interaction between group, attention (attended, ignored)
and emotion (fear, neutral) F(1,39)=5.44, p= .03,
η2 = .122. When ignoring fearful faces (versus ignore-
neutral), depressed patients were significantly less
activated than controls, t(39)=2.28, p=.028, η2 = .12
(uncorrected) but not in the attend condition, p=.17. To
assess change after treatment, we conducted a four-way
ANOVAwith time (pre-treatment, post-treatment) as an
additional factor. The right DLPFC did not show a
significant four-way interaction, p=.17. However theTable 1
Talairach coordinates
Brain region BA Voxel Side x y z
Attention×Emotion×Group
Middle frontal G. 9/46 41 R 36 27 29
Amygdala 28 L −18 −5 −19
Attention×Group
Pregenual cing. 24 33 L −10 35 −2
Emotion×Group
Dorsal cingulate 32 57 R 4 17 41
Main effect of group
Subgenual cing 25 40 L −6 13 −13
Sup.-rostral cing. 24 25 0 13 29
Dorsal cingulate 24 29 0 13 34depressed patients showed a significant increase in
DLPFC activity in the ignore-fear versus ignore-neutral
comparison from time 1 to time-2, F(1,22)=6.21, p=.02,
η2= .220. In contrast, the controls' DLPFC activity for
ignore-fear minus ignore-neutral did not change signifi-
cantly from time-1 to time-2, F(1,17)=2.10, pN .16,
η2= .110.
3.3.2. Amygdala
At time-1, a left amygdala region had also showed
a 3-way interaction between group, attention and emo-
tion, F(1,39)=7.20, p=.011, η2= .156. When ignoring
fearful faces (versus ignore-neutral), depressed patients
were significantly more activated than controls, F(1,39)=
4.31, p=.045, η2= .099, but significantly less activated
for the same contrast in the attend condition, F(1,39)=
4.94, p=.03, η2= .112. Incorporating time-2 data into the
ANOVA, the left amygdala (Fig. 1) showed a significant
four-way interaction, F(1,39)=4.056, p=.05, η2= .094,
because the significant three-way interaction at time-1
disappeared at time-2, pN .3. By time-2, amygdala
activation for the fear-minus-neutral contrast in the
depressed was no longer different from that of controls
at time-2 (both psN .4), nor did they differ from control
values at time-1, (psN .7). However paired t-tests for the
depressed patients alone did not reveal significant
reductions in amygdala activity at time-2 in response to
ignore-fear trials (versus ignore-neutral), (pN .3).
Four other regions showed significant group-related
effects at time-1, but these effects were not normalized at
time-2. These regions were the 1) subgenual cingulate, 2)
pregenual cingulate, 3) an area spanning dorsal/rostral
cingulate, and 4) the dorsal cingulate. These effectsTime-1 effect Time-2 changes in the Depressed
See text Under-activity is normalized. (see text.)
See text No significant changes over time.
Cont: AttendN Ignore No significant changes over time.
Depr: IgnoreNAttend
Cont: NeutralNFear No significant changes over time.
Depr: FearNNeutral
DeprNCont No significant changes over time.
ContNDepr No significant changes over time.
ContNDepr No significant changes over time.
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the Supplementary information.
We tested whether HDRS scores in the patients at
time-2 were related to their time-2 activation values
for the ignore-fear-minus-ignore-neutral contrast, or
whether the percent change in HDRS scores across
time was related to activation changes in the ignore-fear-
minus-ignore-neutral contrast across time. Similar to
time-1, there was no relationship between HDRS scores
at time-2 and activation values at time-2, nor between the
improvement in HDRS scores across time and changes
in ignore-fear contrasts for left amygdala or right
DLPFC, all psN .1.
4. Discussion
This study examined the effects of antidepressant
therapyon activity in dorsolateral PFC and the amygdala in
response to emotional interference during a cognitive task.
Patients showed a significant increase in recruitment of
dorsolateral PFC following treatment, as well as some
reduction (non-significant) of amygdala over-activity in
response to unattended fearful faces. These results suggest
that antidepressant therapymay improve recruitment of the
DLPFC during performance of emotional interference
tasks. Resting hypoactivation in DLPFC has long been a
recognized concomitant of depression (Baxter et al., 1989),
and this resting under-activity has been seen to increase
toward normal levels with antidepressant treatment. The
current study found enhanced task-related activation of
DLPFC following antidepressant treatment (Mayberg et
al., 1999; Kennedy et al., 2001). Enhanced recruitment in
DLPFC has been found to facilitate selective attention to
target stimuli, and also to help individuals regulate emo-
tional responses. Our patients showed no behavioral im-
provements over time, but they were not impaired in the
task even at time-1. However, their reports of improved
mood at time-2 are consistent with enhanced emotion
regulation, and also with FDG-PET studies showing that
antidepressant treatment lowers resting levels of amygdala
hypermetabolism.
Some previous fMRI studies, including our own,
reported that antidepressants normalize amygdala over-
activation in response to negative stimuli (Harmer et al.,
2006; Sheline et al., 2001). In the current study, we
found that depressed individuals showed reduced
amygdala activity following antidepressant treatment,
though this change was not significant. Several of these
previous studies focused on subliminal presentation of
negative stimuli, and the current results may differ
because negative stimuli were unattended but available
to conscious awareness. Several studies have nowposited a reciprocal relationship between the amygdala
and lateral PFC in healthy participants during cognitive
or emotion processing, initially in metabolic studies
(Drevets and Raichle, 1998) and more recently during a
cognitive task with emotional distracters (Dolcos and
McCarthy, 2006). In such studies, it has been suggested
that either increased amygdala activity suppresses
DLPFC activity, or increased DLPFC activity serves
to suppress amygdala activity. Given the patients'
improved mood in the current study, it is possible that
reductions in resting amygdala did take place, and this
reduction may have prevented bottom-up suppression of
DLPFC by amygdala activity, thus enabling patients to
recruit DLPFC normally during task performance.
Potentially, changes in resting amygdala activity could
occur without significant reductions in task-evoked
amygdala response.
We did not find that antidepressant therapy normal-
ized activation in subgenual or dorsal/rostral cingulate
cortex. Elevated activity in subgenual cortex is a com-
mon finding in studies of major depression, and meta-
bolic hyperactivity in this region has been seen to resolve
with antidepressant therapy (Mayberg et al., 1999). In
contrast, in the current study, only the DLPFC showed
significant normalization of activity following antide-
pressant treatment, suggesting that subgenual PFC
hyperactivity and reduced DLPFC activity in major
depression may be dissociable phenomena that reflect
different mechanisms.
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